REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 104 filers reported holding REGULUS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,538,000 | -31.3% | 4,683,489 | +0.7% | 0.00% | -25.0% |
| Q3 2016 | $15,341,000 | +8.6% | 4,648,815 | -4.9% | 0.00% | 0.0% |
| Q2 2016 | $14,121,000 | -49.5% | 4,886,125 | +21.2% | 0.00% | -42.9% |
| Q1 2016 | $27,938,000 | -24.0% | 4,031,571 | -4.3% | 0.01% | -30.0% |
| Q4 2015 | $36,745,000 | +33.2% | 4,213,856 | -0.1% | 0.01% | +25.0% |
| Q3 2015 | $27,586,000 | -48.1% | 4,217,986 | -13.1% | 0.01% | -42.9% |
| Q2 2015 | $53,194,000 | -42.0% | 4,853,442 | -10.3% | 0.01% | -41.7% |
| Q1 2015 | $91,656,000 | +51.2% | 5,410,597 | +43.2% | 0.02% | +50.0% |
| Q4 2014 | $60,618,000 | +744.4% | 3,779,174 | +259.6% | 0.02% | +700.0% |
| Q3 2014 | $7,179,000 | -5.0% | 1,050,980 | +11.8% | 0.00% | 0.0% |
| Q2 2014 | $7,558,000 | +12.5% | 940,070 | +26.2% | 0.00% | 0.0% |
| Q1 2014 | $6,719,000 | +13.0% | 744,960 | -7.4% | 0.00% | 0.0% |
| Q4 2013 | $5,947,000 | – | 804,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
| HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
| Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
| BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
| Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
| Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
| LMR Partners LLP | 11,815 | $106,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |